Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
Stent implantation is an alternative, safe, and reliable strategy for the treatment of chronic mesenteric ischemia, especially for patients at high surgical risk. However, in-stent restenosis (the Achille's hill of bare metal stent) may occur in up to 20% of cases at 6 months and 53% at 1 year. We describe a case of celiac trunk stenosis treated by bare metal stent complicated by recalcitrant in-stent restenosis and treated by paclitaxel-eluting stent implantation.
Visconti
Gabriella
G
Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy.
Taranto
Domenico
D
Briguori
Carlo
C
D000368:Aged; D000800:Angioplasty, Balloon / Q000009:adverse effects / Q000295:instrumentation*; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000473:pathology / Q000628:therapy*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D002445:Celiac Artery / Q000473:pathology; D002908:Chronic Disease; D003251:Constriction, Pathologic; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D007511:Ischemia / Q000209:etiology / Q000628:therapy; D018810:Magnetic Resonance Angiography; D008641:Mesenteric Vascular Occlusion / Q000150:complications / Q000473:pathology / Q000628:therapy*; D008670:Metals; D017239:Paclitaxel / Q000008:administration & dosage*; D011474:Prosthesis Design; D012008:Recurrence; D015607:Stents; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D008670:Metals; D017239:Paclitaxel